Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
An intro to the components behind the S&P 500 index value, including inputs and how they combine to form the level.
27,867 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Upstart has been navigating a challenging stretch as the stock declines. This article breaks down whether the drop cr...
A new industry focus centers on converting existing leads. Real estate teams report faster traction by prioritizing f...
A wave of at-home red light therapy devices is gaining traction as Americans weigh costs and potential skincare and r...
A Mission Produce director just bought a multi-million-dollar stake in AVO. This article breaks down what insider buy...
EasyJet reaches a takeover price with a U.S. investor, valuing the airline at about £2.6 billion, but traders doubt t...
Procter & Gamble has built a remarkable dividend-growth legacy, raising payouts for seven decades. This article break...
Top earners weigh a move from California to Texas as california high income taxes bite paychecks, but rising Texas pr...
A 6% weekly pullback can feel painful, but for patient buyers, this growth stock march story is about resilience, rev...
When leaders sell stock alongside stronger earnings, investors should look beyond headlines. This guide breaks down i...
When markets wobble, patient investors can unlock real opportunities. This guide breaks down a clear process to spot ...
In 2026, misfired AI layoff messaging draws public boos and investor scrutiny. This report traces how leaders’ word c...